These final results, together with a earlier report showing that a little-molecule ACKR3 agonist CCX771 displays anxiolytic-like actions in mice,2 guidance the thought of focusing on ACKR3 as a unique way to modulate the opioid technique, which could open up new therapeutic avenues for opioid-related disorders.We independently exploration, critique